首页|期刊导航|武警医学|Janus激酶1抑制剂伊他替尼治疗小鼠自身免疫性肝炎的药效评价

Janus激酶1抑制剂伊他替尼治疗小鼠自身免疫性肝炎的药效评价OA

Evaluation of the therapeutic efficacy of JAK1 inhibitor of Imatinib in the treatment of autoimmune hepatitis in mice

中文摘要英文摘要

目的 探究 Janus 激酶 1(JAK1)抑制剂伊他替尼(ITA)治疗小鼠自身免疫性肝炎(AIH)的效果.方法 将30 只雄性 BALB/c 小鼠随机分为空白对照组、模型组和 ITA 组,每组 10 只.模型组和 ITA 组小鼠通过尾静脉注射刀豆蛋白 A(Con A)25 mg/kg 建立AIH 模型,空白对照组注射等量生理盐水.造模30 min 后,ITA 组腹腔给予伊他替尼(10 mg/kg),空白对照组和模型组给予等量生理盐水.Con A 注射 8 h 后处死小鼠,采集血清及肝组织样本.采用 HE 染色观察肝组织病理学变化,分别测定血清肝功能指标、炎症因子水平和肝组织 CD3+T 细胞、CD4+T 细胞浸润比例.结果 与空白对照组相比,模型组小鼠肝脏出现明显肿大、充血及点状出血灶,肝小叶结构紊乱并伴有大面积肝细胞坏死;血清 ALT、AST 水平及 TNF-α、IL-6、IL-2含量均升高;肝组织内CD3+T细胞及 CD4+T 细胞浸润比例也增加(均 P<0.05),差异具有统计学意义.与模型组相比,ITA 组小鼠肝脏外观及病理结构明显改善,肝损伤区域减小;血清ALT和AST水平及TNF-α、IL-6及IL-2水平均下降;肝组织中CD3+T细胞及CD4+T细胞浸润比例亦减少(均P<0.05),差异具有统计学意义.结论 ITA 能有效减轻Con A 诱导的 AIH 小鼠肝损伤,其机制可能与抑制JAK1信号通路,从而减少T淋巴细胞浸润及炎症因子(TNF-α、IL-6、IL-2)的释放有关.

Objective To investigate the therapeutic efficacy of Janus kinase 1(JAK1)inhibitor of Itacitinib(ITA)on auto-immune hepatitis(AIH)in mice.Methods A total of 30 male BALB/c mice were randomly divided into three groups with 10 mice in each group:a blank control group,a model group,and an ITA group.AIH models were established by tail vein injection of concanava-lin A(Con A)at a dose of 25 mg/kg in the model and ITA groups,while the control group received an equal volume of normal saline.Thirty minutes after modeling,the ITA group was intraperitoneally administered ITA(10 mg/kg),whereas the control and model groups received an equal volume of saline.All mice were euthanized for 8 hours after the Con A injection,and serum and liver tissue samples were collected.Histopathological changes in liver tissues were observed using HE staining,and serum levels of liver function markers,inflammatory cytokines,as well as the infiltration proportions of CD3+T cells and CD4+T cells in liver tissue were measured.Results Compared with the blank control group,the model group exhibited significant liver enlargement,congestion,and spotted hemorrhages,disordered hepatic lobule structure and extensive hepatocellular necrosis;serum levels of ALT and AST,as well as TNF-α,IL-6,and IL-2 concentrations were significantly elevated;infiltration proportions of both CD3+T cells and CD4+T cells in the liver tissues also increased(P<0.05),indicating statistically signifi-cant differences.Compared with the model group,the ITA group showed obvious improvements in liver appearance and pathological structure,with reduced areas of liver damage,decreased serum ALT and AST levels and lower levels of TNF-α and IL-6;infiltration ratios of CD3+T cells and CD4+T cells in the liver tissue were also re-duced(all P<0.05),showing statistically significant differences.Conclusions ITA can effectively alleviate liver damage in Con A-induced AIH mice,possibly through inhibition of the JAK1 signaling pathway,thereby reducing T lymphocyte infiltration and the re-lease of inflammatory cytokines(TNF-α,IL-6,and IL-2).

米丽;贾蔚;花冠春;陈建军;李敬超

201103,武警上海总队医院药剂科201103,武警上海总队医院卫生防疫科201103,武警上海总队医院内一科201103,武警上海总队医院卫勤处202763 海口,武警海南总队医院药剂科

医药卫生

JAK1 抑制剂自身免疫性肝炎伊他替尼刀豆蛋白 A炎症细胞因子

JAK1 inhibitorautoimmune hepatitisItacitinibconcanavalin ainflammatory cytokines

《武警医学》 2026 (9)

737-741,5

武警部队某课题资助

10.3969/j.issn.1004-3594.2026.09.001

评论